{
  "id": 469105,
  "num_rows": 1000,
  "file_format": "json",
  "name": "Immunotherapy",
  "array": true,
  "columns": [
    {
      "name": "program_id",
      "null_percentage": 0,
      "type": "Blank",
      "formula": ""
    },
    {
      "name": "submitter_donor_id",
      "null_percentage": 0,
      "type": "Blank",
      "formula": ""
    },
    {
      "name": "submitter_treatment_id",
      "null_percentage": 0,
      "type": "Blank",
      "formula": ""
    },
    {
      "name": "immunotherapy_type",
      "null_percentage": 10,
      "type": "Template",
      "value": "",
      "formula": "[\"Cell-based\",\n\"Immune checkpoint inhibitors\",\n\"Monoclonal antibodies other than immune checkpoint inhibitors\",\n\"Other immunomodulatory substances\"][random(0,3)]"
    },
    {
      "name": "drug_name",
      "null_percentage": 11,
      "type": "Template",
      "value": "",
      "formula": "[\"Pembrolizumab\",\n    \"Belantamab\",\n    \"Copanlisib\",\n    \"Gilteritinib\",\n    \"Necitumumab\",\n    \"Pexidartinib\",\n    \"Selumitinib\",\n    \"Atezolizumab\",\n    \"Durvalumab\",\n    \"Tecentriq\",\n    \"Nivolumab\",\n    \"Opdivo\",\n    \"Ipilimumab\",\n    \"Yervoy\",\n    \"Tisagenlecleucel\",\n    \"Kymriah\",\n    \"Axicabtagene ciloleucel\",\n    \"Yescarta\",\n    \"Brentuximab vedotin\",\n    \"Adcetris\",\n    \"Rituximab\",\n    \"Rituxan\",\n    \"Obinutuzumab\",\n    \"Gazyva\",\n    \"Daratumumab\",\n    \"Darzalex\",\n    \"Inotuzumab ozogamicin\",\n    \"Besponsa\",\n    \"Blinatumomab\",\n    \"Blincyto\",\n    \"Venetoclax\",\n    \"Venclexta\",\n    \"Palbociclib\",\n    \"Ibrance\",\n    \"Ribociclib\",\n    \"Kisqali\",\n    \"Abemaciclib\",\n    \"Verzenio\",\n    \"Olaparib\",\n    \"Lynparza\",\n    \"Rucaparib\",\n    \"Rubraca\",\n    \"Niraparib\",\n    \"Zejula\",\n    \"Pembrolizumab\",\n    \"Keytruda\",\n    \"Atezolizumab\",\n    \"Tecentriq\",\n    \"Durvalumab\",\n    \"Imfinzi\",\n    \"Nivolumab\",\n    \"Opdivo\",\n    \"Ipilimumab\",\n    \"Yervoy\",\n    \"Pembrolizumab\",\n    \"Keytruda\",\n    \"Nivolumab\",\n    \"Opdivo\",\n    \"Atezolizumab\",\n    \"Tecentriq\",\n    \"Durvalumab\",\n    \"Imfinzi\",\n    \"Ipilimumab\",\n    \"Yervoy\",\n    \"Pembrolizumab\",\n    \"Keytruda\",\n    \"Atezolizumab\",\n    \"Tecentriq\",\n    \"Nivolumab\",\n    \"Opdivo\",\n    \"Ipilimumab\",\n    \"Yervoy\",\n    \"Trastuzumab\",\n    \"Herceptin\",\n    \"Pertuzumab\",\n    \"Perjeta\",\n    \"Ado-trastuzumab emtansine\",\n    \"Kadcyla\",\n    \"Fam-trastuzumab deruxtecan-nxki\",\n    \"Enhertu\",\n    \"Lenvatinib\",\n    \"Lenvima\",\n    \"Sorafenib\",\n    \"Nexavar\",\n    \"Cabozantinib\",\n    \"Cometriq\",\n    \"Vandetanib\",\n    \"Caprelsa\",\n    \"Osimertinib\",\n    \"Tagrisso\",\n    \"Afatinib\",\n    \"Gilotrif\",\n    \"Erlotinib\",\n    \"Tarceva\",\n    \"Gefitinib\",\n    \"Iressa\",\n    \"Crizotinib\",\n    \"Xalkori\",\n    \"Ceritinib\",\n    \"Zykadia\",\n    \"Alectinib\",\n    \"Alecensa\",\n    \"Brigatinib\",\n    \"Alunbrig\",\n    \"Dabrafenib\",\n    \"Tafinlar\",\n    \"Trametinib\",\n    \"Mekinist\",\n    \"Vemurafenib\",\n    \"Zelboraf\",\n    \"Cobimetinib\",\n    \"Cotellic\",\n    \"Encorafenib\",\n    \"Braftovi\",\n    \"Binimetinib\",\n    \"Mektovi\"][random(0,115)]\n"
    },
    {
      "name": "drug_reference_identifier",
      "null_percentage": 12,
      "type": "Template",
      "value": "",
      "formula": "[\"239766\",\n\"8836851\",\n\"4459876\",\n\"278936\",\n\"8756456\",\n\"987654\"][random(0,5)]"
    },
    {
      "name": "drug_reference_database",
      "null_percentage": 13,
      "type": "Template",
      "value": "",
      "formula": " [\n    \"RxNorm\",\n    \"PubChem\",\n    \"NCI Thesaurus\",\n][random(0,2)]"
    },
    {
      "name": "immunotherapy_drug_dose_units",
      "null_percentage": 14,
      "type": "Template",
      "value": "",
      "formula": "[\n    \"mg/m2\",\n    \"IU/m2\",\n    \"IU/kg\",\n    \"ug/m2\",\n    \"g/m2\",\n    \"mg/kg\",\n    \"cells/kg\",\n][random(0,6)]"
    },
    {
      "name": "prescribed_cumulative_drug_dose",
      "null_percentage": 15,
      "type": "Number",
      "min": 50,
      "max": 200,
      "decimals": null,
      "formula": null
    },
    {
      "name": "actual_cumulative_drug_dose",
      "null_percentage": 16,
      "type": "Number",
      "min": 50,
      "max": 200,
      "decimals": null,
      "formula": null
    }
  ]
}